Hematology and Oncology Study Experience

  • Acute myelogenous leukemia (AML)
  • Anal
  • Anemia
  • Anti-thrombin deficiency
  • Bladder
  • Brain
  • Breast
  • Cervical
  • Chronic lymphocytic leukemia (CLL)
  • Chronic myelogenous leukemia (CML)
  • Colorectal
  • Cutaneous T-cell lymphoma
  • Gastric
  • Glioblastoma multiforme (GBM)
  • Thrombocythemia
  • Thyroid
  • Uterus
  • Hemophilia
  • Hepatic
  • Leptomeningeal carcinoma
  • Melanoma
  • Mucositis
  • Multiple myeloma deficiency
  • Myelodysplastic syndromes
  • Myeloproliferative disease
  • Non-Hodgkins lymphoma
  • Non-small cell lung cancer (NSCLC)
  • Ovary
  • Pancreas
  • Post-herpetic neuralgia (PHN)
  • Prostate
  • Renal cell
  • Squamous cell carcinoma (SCCHN
  • Skin

Therapeutic Clinical Research Experience

  • Antiangiogenic agents
  • Antisense therapy
  • Biological response modifier (e.g., cytokines, MAb)
  • Chemosensitizers
  • Cytotoxics (systemic and topical)
  • Gene therapy
  • Hematopoietic growth factors
  • Hormonal therapy
  • Radioisotopes
  • Radiotherapy
  • Regional administration
  • Targeted therapy

Hematology and Oncology Study Experience

Awarded Hematology/Oncology Experience by Phase (past five years)

Phase Number of Studies
I 81
II 109
III 125
IV 34